JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages

International Immunopharmacology
Riina NieminenEeva Moilanen

Abstract

Inducible prostaglandin synthase (cyclooxygenase-2, COX-2) is highly expressed in inflammation. The signaling mechanisms involved in the up-regulation of COX-2 are not known in detail. In the present study we investigated the role of c-Jun NH2-terminal kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family in COX-2 expression and prostaglandin (PG) E2 production in murine J774 macrophages activated by bacterial lipopolysaccharide (LPS). LPS caused a transient activation of JNK which was followed by increased COX-2 expression. Anthra(1,9-cd)pyrazol-6(2H)-one (SP600125), an inhibitor of JNK, inhibited phosphorylation of c-Jun with an IC50 of 5-10 microM. At the same concentrations SP600125 suppressed also LPS-induced COX-2 protein levels and PGE2 production. SP600125 did not alter LPS-induced COX-2 mRNA levels when measured 3 h after addition of LPS, whereas mRNA levels were significantly reduced in SP600125-treated cells when measured 24 h after addition of LPS. LPS-induced COX-2 mRNA levels reduced faster in cells treated with SP600125 than in control cells. Cycloheximide (that is known to activate JNK) enhanced COX-2 expression and its effect was inhibited by SP600125. The present results suggest that JNK...Continue Reading

References

Jan 1, 1986·Annual Review of Biochemistry·P NeedlemanJ B Lefkowith
Dec 8, 1995·The Journal of Biological Chemistry·C SeiserL C Kühn
Jul 1, 1996·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J M Kyriakis, J Avruch
Jun 1, 1996·Current Opinion in Immunology·B Su, M Karin
May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
Apr 15, 2000·The Journal of Biological Chemistry·D A DixonS M Prescott
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·B L BennettD W Anderson
Jan 31, 2002·Annual Review of Medicine·Marco E Turini, Raymond N DuBois
Feb 28, 2002·Annual Review of Immunology·Chen DongRichard A Flavell
Dec 14, 2002·The Journal of Biological Chemistry·Wangsheng YuAlan P Fields
Jan 22, 2003·The Biochemical Journal·Jenny BainPhilip Cohen
Apr 1, 2003·Molecular and Cellular Biology·Juan-Jose VenturaRoger J Davis
Apr 22, 2003·The Journal of Biological Chemistry·Sibani SenguptaTimothy Hla
Jun 27, 2003·The Journal of Biological Chemistry·Kotha SubbaramaiahAndrew J Dannenberg
Nov 1, 2005·Mediators of Inflammation·Riina NieminenEeva Moilanen

❮ Previous
Next ❯

Citations

Mar 6, 2013·Canadian Journal of Physiology and Pharmacology·Ji-Youn LimSo-Young Park
Jan 20, 2016·Journal of Neuroinflammation·Antonio Carlos Pinheiro de OliveiraBernd L Fiebich
Jun 12, 2014·Kidney International·Shipra AgrawalWilliam E Smoyer
Apr 9, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karina Trujillo-MurilloAna María Rivas-Estilla
Apr 1, 2016·Connective Tissue Research·David T Broome, Nabanita S Datta
Oct 20, 2007·Biochimica Et Biophysica Acta·Thomas KleinMartin Kömhoff
Sep 14, 2006·The Korean Journal of Parasitology·Ji-Young KimMyung-Hwan Cho
Apr 12, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria Barberà-CremadesPablo Pelegrín
May 27, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Veronica Ramirez-AlcantaraUrs A Boelsterli
Aug 19, 2018·Journal of Experimental & Clinical Cancer Research : CR·Yongkui LiLin Wang
May 15, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Su Bin ParkJin Boo Jeong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.